Search Keyword

Organic Search Competitive Analysis

Top Most Websites for keyword: "nivolumab lung cancer"

OPDIVO® (nivolumab) | Patients | Advanced NSCLC

http://www.opdivo.com/advanced-nsclc

OPDIVO® (nivolumab) is a prescription medicine used to treat a type of
advanced stage lung cancer (called non-small cell lung cancer) that has spread
or ...

opdivo.com

Nivolumab versus Docetaxel in Advanced Nonsquamous Non ...

http://www.nejm.org/doi/full/10.1056/NEJMoa1507643

Sep 27, 2015 ... Original Article. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–
Small-Cell Lung Cancer. Hossein Borghaei, D.O., Luis ...

nejm.org

Nivolumab in Lung Cancer Shows Unprecedented Survival

http://www.medscape.com/viewarticle/845647

May 29, 2015 ... Nivolumab is the new standard of care in patients with previously treated
squamous nonsmall cell lung cancer (NSCLC), declared Roy Herbst, ...

medscape.com

Nivolumab in advanced lung cancer: Indication of major added benefit

https://www.sciencedaily.com/releases/2016/08/160818131525.htm

Aug 18, 2016 ... Patients with advanced nonsquamous NSCLC who have already undergone
chemotherapy survive longer with the drug Nivolumab than with ...

sciencedaily.com

Nivolumab Fails as Initial Lung Cancer Treatment

http://www.medscape.com/viewarticle/867169

Aug 5, 2016 ... The immunotherapy nivolumab (Opdivo, Bristol-Myers Squibb) has failed as a
first-line monotherapy for lung cancer. The drug did not meet its ...

medscape.com

Nivolumab Monotherapy for First-Line Treatment of Advanced Non ...

http://ascopubs.org/doi/full/10.1200/jco.2016.66.9929

Platinum-based doublet chemotherapy (PT-DC) is the current standard of care as
first-line treatment of patients with advanced non–small-cell lung cancer ...

ascopubs.org

FDA Approves Opdivo (Nivolumab) for Lung Cancer

https://www.cancer.org/latest-news/fda-approves-opdivo-nivolumab-for-lung-cancer.html

Mar 5, 2015 ... The US Food and Drug Administration (FDA) has approved Opdivo (nivolumab)
to treat people with a type of advanced lung cancer: squamous ...

cancer.org

CRI - Lung Cancer Immunotherapy - Cancer Research Institute

https://www.cancerresearch.org/we-are-cri/home/cancer-types/lung-cancer

Discover the promise of immunotherapy as a revolutionary new treatment for lung
cancer with the potential to cure more lung cancers and save more lives.

cancerresearch.org

Five-year Survival Rate For Nivolumab-treated Advanced Lung ...

http://www.aacr.org/Newsroom/Pages/News-Release-Detail.aspx?ItemID=1031

Five-year Survival Rate For Nivolumab-treated Advanced Lung Cancer Patients
Much Higher Than Historical Rate. 4/3/2017. ​WASHINGTON — Treatment with
 ...

aacr.org

First-line immunotherapy treatment can improve survival for subset ...

https://www.sciencedaily.com/releases/2017/06/170621190037.htm

Jun 21, 2017 ... Findings from a phase III clinical trial for advanced lung cancer patients ... tumor
mutations and PDL-1 positive status respond to nivolumab.

sciencedaily.com